These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38763036)

  • 1. Characterisation of a novel AmpC beta-lactamase, DHA-33, resistant to inhibition by cloxacillin.
    Findlay J; Poirel L; Cherkaoui A; Schrenzel J; Nordmann P
    Diagn Microbiol Infect Dis; 2024 Aug; 109(4):116356. PubMed ID: 38763036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coli.
    Mirelis B; Rivera A; Miró E; Mesa RJ; Navarro F; Coll P
    Enferm Infecc Microbiol Clin; 2006; 24(6):370-2. PubMed ID: 16792938
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Stewart AG; Cottrell K; Henderson A; Vemuri K; Bauer MJ; Paterson DL; Harris PNA
    Microbiol Spectr; 2021 Sep; 9(1):e0022621. PubMed ID: 34232101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis.
    Peter-Getzlaff S; Polsfuss S; Poledica M; Hombach M; Giger J; Böttger EC; Zbinden R; Bloemberg GV
    J Clin Microbiol; 2011 Aug; 49(8):2924-32. PubMed ID: 21653764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Carriage of Extended-Spectrum β-Lactamases and pAmpC Producing
    Habibzadeh N; Peeri Doghaheh H; Manouchehri Far M; Alimohammadi Asl H; Iranpour S; Arzanlou M
    Microb Drug Resist; 2022 Sep; 28(9):921-934. PubMed ID: 36067095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugative plasmidic AmpC detected in Escherichia coli, Proteus mirabilis and Klebsiella pneumoniae human clinical isolates from Portugal.
    Santiago GS; Gonçalves D; da Silva Coelho I; de Mattos de Oliveira Coelho S; Neto Ferreira H
    Braz J Microbiol; 2020 Dec; 51(4):1807-1812. PubMed ID: 32740783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China.
    Li Y; Li Q; Du Y; Jiang X; Tang J; Wang J; Li G; Jiang Y
    J Clin Microbiol; 2008 Apr; 46(4):1317-21. PubMed ID: 18305137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
    Tan TY; Ng LS; He J; Koh TH; Hsu LY
    Antimicrob Agents Chemother; 2009 Jan; 53(1):146-9. PubMed ID: 18955528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination and characterisation of Escherichia coli producing extended-spectrum β-lactamases, AmpC β-lactamases and metallo-β-lactamases from livestock and poultry in Northeast India: A molecular surveillance approach.
    Tewari R; Mitra S; Ganaie F; Das S; Chakraborty A; Venugopal N; Shome R; Rahman H; Shome BR
    J Glob Antimicrob Resist; 2019 Jun; 17():209-215. PubMed ID: 30634056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
    Pires J; Taracila M; Bethel CR; Doi Y; Kasraian S; Tinguely R; Sendi P; Bonomo RA; Endimiani A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7483-8. PubMed ID: 26392491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of AmpC beta-lactamase and extended spectrum beta-lactamase co-producer in Escherichia coli and Klebsiella species in a teaching hospital.
    Ting SMV; Ismail Z; Hanafiah A
    Malays J Pathol; 2024 Apr; 46(1):79-89. PubMed ID: 38682847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and molecular characterization of plasmid mediated AmpC β-lactamases among Escherichia coli, Klebsiella spp., and Proteus mirabilis isolated from urinary tract infections in Egyptian hospitals.
    Helmy MM; Wasfi R
    Biomed Res Int; 2014; 2014():171548. PubMed ID: 25003107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Lactamases in amoxicillin-clavulanate-resistant Escherichia coli strains isolated from a Chinese tertiary hospital.
    Ding J; Ma X; Chen Z; Feng K
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):532-3. PubMed ID: 23726651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of fosfomycin resistance among isolates of Escherichia coli harboring extended-spectrum and AmpC β-lactamases.
    Bahramian A; Eslami G; Hashemi A; Tabibi A; Heidary M
    Acta Microbiol Immunol Hung; 2018 Mar; 65(1):15-25. PubMed ID: 29137487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan.
    Yan JJ; Hsueh PR; Lu JJ; Chang FY; Shyr JM; Wan JH; Liu YC; Chuang YC; Yang YC; Tsao SM; Wu HH; Wang LS; Lin TP; Wu HM; Chen HM; Wu JJ
    Antimicrob Agents Chemother; 2006 May; 50(5):1861-4. PubMed ID: 16641462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique.
    Estaleva CEL; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Simonsen GS; Haldorsen B; Essack SY; Sundsfjord A
    BMC Infect Dis; 2021 Jan; 21(1):16. PubMed ID: 33407206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of high-level cephalosporinase due to mutation in the AmpC attenuator of a clinical Escherichia coli strain].
    Guan XZ; Liu YN; Luo YP; She DY; Lu SJ; Zhou G; Chen LA
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):600-4. PubMed ID: 16681904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
    Zerr DM; Miles-Jay A; Kronman MP; Zhou C; Adler AL; Haaland W; Weissman SJ; Elward A; Newland JG; Zaoutis T; Qin X
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4237-43. PubMed ID: 27139486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.